Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database.
- DOI
- 10.1093/jvimsj/aalag193
- Published
- 2026 Sep 1
- Container
- Journal of veterinary internal medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/jvimsj/aalag193,
title = {Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database.},
author = {Lai X and Chen M and Huang Y and Cheng Y},
year = {2026},
journal = {Journal of veterinary internal medicine},
doi = {10.1093/jvimsj/aalag193},
url = {https://doi.org/10.1093/jvimsj/aalag193}
}RIS
TY - JOUR TI - Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database. AU - Lai X AU - Chen M AU - Huang Y AU - Cheng Y PY - 2026 JO - Journal of veterinary internal medicine DO - 10.1093/jvimsj/aalag193 UR - https://doi.org/10.1093/jvimsj/aalag193 ER -
APA
X, L., M, C., Y, H., & Y, C. (2026). Post-marketing safety monitoring of sodium-glucose cotransporter 2 inhibitors for diabetes in cats: a pharmacovigilance study based on the FDA ADAE database.. Journal of veterinary internal medicine. https://doi.org/10.1093/jvimsj/aalag193
Source records
- pubmed · retrieved 2026-09-25T10:58:12.314Z
- europe-pmc · retrieved 2026-09-25T10:58:12.300Z